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Abstract
Introduction:  The  identiﬁcation  of  subepithelial  lesions  is  a  relatively  frequent  ﬁnding  at
endoscopy  however  their  natural  history  is  not  well  known.  Our  aim  was  to  analyze  the  role
of endoscopic  ultrasound  (EUS)  in  the  diagnostic  approach  of  subepithelial  lesions  of  the  upper
gastrointestinal  tract.
Methods:  Retrospective  study  which  included  324  patients  undergoing  upper  radial  EUS  for
evaluation  of  subepithelial  lesions  from  2008  to  2014.  The  EUS  features,  presumptive  diagnosis
and management  decision  were  analyzed.
Results:  324  patients  included,  60%  with  gastric  subepithelial  lesions,  28%  oesophageal  and  12%
from the  duodenum.  Based  on  EUS  features  the  presumptive  diagnosis  was:  25%  gastrointesti-
nal stromal  tumor,  21%  lipoma,  19%  leiomyoma,  17%  pancreatic  rest,  7%  submucosa  cysts,  1%
granular cell  tumors,  1%  carcinoids,  1%  mucosa  lesions  and  8%  not  deﬁned.  After  EUS  the  sug-
gested approach  was  no  follow-up  in  45%,  follow-up  with  re-examination  with  EUS  in  35%  and
additional  tissue  sampling  or  endoscopic/surgical  resection  in  20%.  The  latter  was  based  on  EUS
features of  risk  at  the  diagnosis  (53%),  such  as  size  ≥2  cm,  hypoechogenicity,  heterogeneity,
lobulation,  calciﬁcations,  cystic  component  and  regional  adenopathies;  impossibility  to  deﬁne
a presumptive  diagnosis  (39%)  or  EUS  features  change  at  follow-up  (8%).  The  combination  of
multiple features  correlated  with  a  higher  probability  of  this  recommended  strategy  (p  <  0.001),
in 100%  when  4  or  more  features  were  present.  Among  the  33  patients  who  underwent  ﬁne  nee-
dle aspiration,  in  66%  the  result  was  inconclusive.  During  follow-up,  none  of  the  patients  who
lance  radial  EUS  presented  complications.were managed  with  surveil∗ Corresponding author.
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Conclusion:  EUS  is  the  method  of  choice  in  the  study  of  subepithelial  lesions  of  the  upper
gastrointestinal  tract,  in  most  cases  deﬁning  a  diagnosis.  The  need  for  a  deﬁnitive  diagnosis  or
therapeutic  approaches  can  be  based  on  ultrasound  risk  features,  presented,  in  the  majority,
at presentation.  This  study  shows  that  EUS  is  capable  of  safely  and  accurately  deﬁne  those
subepithelial  lesions  that  can  be  managed  only  with  surveillance  ultrasound  while  waiting  for
better results  with  ﬁne  needle  aspiration.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Papel  da  Ultrassonograﬁa  Endoscópica  na  Abordagem  Diagnóstica  das  Lesões
Subepiteliais  Altas
Resumo
Introduc¸ão:  As  lesões  subepiteliais  (LS)  são  achados  frequentes,  particularmente  no  trato  diges-
tivo alto.  Incluem  um  grande  número  de  entidades,  algumas  com  potencial  maligno,  cuja
história natural  não  é  totalmente  conhecida  e  o  adequado  manejo  controverso.  O  nosso  obje-
tivo foi  analisar  o  papel  da  ultrassonograﬁa  endoscópica  (EUS)  na  abordagem  diagnóstica  das
LS do  trato  digestivo  alto.
Material:  Estudo  retrospetivo  de  doentes  consecutivos  submetidos  a  EUS  alta  para  estudo  diag-
nóstico de  LS  entre  2008-2014.  Analisadas  as  características  ultrassonográﬁcas  e  a  orientac¸ão
deﬁnida.
Resultados:  Incluídos  324  doentes,  60%  com  LS  gástrica,  28%  esofágica  e  12%  duodenal.  O  diag-
nóstico segundo  as  características  ultrassonográﬁcas  foi:  GIST  25%,  lipoma  21%,  leiomioma  19%,
pâncreas ectópico  17%,  quisto  submucosa  7%,  tumor  células  granulares  1%,  carcinoide  1%,  lesões
da mucosa  1%  e  em  8%  indeﬁnido.  A  orientac¸ão  proposta  após  EUS  foi  em  35%  de  vigilância  e
em 20%  intervenc¸ão  diagnóstica/terapêutica  (punc¸ão  aspirativa  agulha  ﬁna  -  PAAF  ou  ressecc¸ão
cirúrgica/endoscópica).  Esta  última  por  características  EUS  de  agressividade  no  diagnóstico
(53%), diagnóstico  indeﬁnido  em  EUS  (39%)  ou  alterac¸ões  de  tamanho  em  EUS  subsequentes
(8%). As  características  EUS  associadas  signiﬁcativamente  à  decisão  de  PAAF/ressecc¸ão  foram:
tamanho,  hipoecogenicidade,  heterogeneidade,  bordos  irregulares,  calciﬁcac¸ões,  componente
quístico e  adenopatias.  A  associac¸ão  de  várias  características  associou-se  a  maior  percentagem
de doentes  submetidos  a  esta  abordagem  (p  <  0,001),  em  100%  quando  4  ou  mais  critérios.  Nos
33 doentes  submetidos  a  PAAF,  em  66%  o  diagnóstico  foi  inconclusivo.  Em  todas  as  LSE  orientadas
para vigilância  não  se  veriﬁcaram  intercorrências  neste  período.
Conclusão:  A  EUS  é  o  método  de  eleic¸ão  no  estudo  das  LS  do  trato  digestivo  alto,  na  maioria
deﬁnindo um  diagnóstico.  A  abordagem  diagnóstica  deﬁnitiva  ou  terapêutica,  pode  ser  baseada
na associac¸ão  de  características  ultrassonográﬁcas  de  agressividade,  apresentadas  na  maioria
logo no  diagnóstico  inicial.  Foi  demonstrada  seguranc¸a nas  LSE  orientadas  para  vigilância  e  a
necessidade  de  aguardar  melhores  resultados  com  PAAF.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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w. Introduction
he  identiﬁcation  of  a  mass  covered  by  normal-appearing
ucosa  is  a  relatively  frequent  ﬁnding  at  endoscopy,
pproximately  0.3%  of  all  upper  GI  endoscopies.1--3 These
asses,  more  correctly  referred  as  subepithelial  lesions
SL),  can  arise  from  within  any  layer  of  the  gas-
rointestinal  wall.1 They  occur  more  frequently  in  the
tomach,  but  are  also  common  in  the  esophagus  and
uodenum.4 Common  examples  include  gastrointestinal
tromal  tumor  (GIST),  leiomyoma,  leiomyosarcoma,  car-
inoid,  granular  cell  tumors,  lipoma,  pancreatic  rest,
E
o
t
echwannoma,  etc.5 The  majority  of  subepithelial  lesions
re  benign  at  the  time  of  diagnosis,  with  fewer  than
5%  found  to  be  malignant  at  presentation.  However
any  of  these  lesions  have  the  potential  for  malignant
ransformation.6
The  differential  diagnosis  of  these  lesions  is  broad  and
anges  from  clinically  insigniﬁcant  to  malignant  conditions,
hich  underlines  the  importance  of  an  accurate  diagnosis.
ndoscopy  alone  is  not  reliable  for  the  deﬁnitive  diagnosis
f  subepithelial  lesions  and  frequently  they  are  inciden-
ally  detected,  not  explaining  the  indication  for  endoscopic
xamination.7
Endoscopic  ultrasound  and  Subepithelial  lesions  
Figure  1  GIST-EUS  shows  a  heterogeneous  hypoechoic  lesion
of the  forth  gastric  wall  layer  with  lobulation  measuring
10 ×  6  cm.
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dFigure  2  GIST-EUS  shows  a  heterogeneous  hypoechoic  lesion
of the  forth  gastric  wall  layer  with  lobulation  measuring
8.0 ×  6.6  cm.
Histology  is  the  ‘‘gold  standard’’  to  differentiate
between  the  different  types  of  subepithelial  lesions,  how-
ever  this  evaluation  can  only  be  obtained  through  invasive
techniques  such  as  endoscopic  mucosal  resection,  ﬁne-
needle  aspiration  (EUS-FNA),  or  surgical  resection.8 The  role
of  less  invasive  techniques  such  as  endoscopic  ultrasound
(EUS)  remains  unclear.  EUS  has  the  ability  to  differentiate
extramural  compression  from  intramural  growth,  determine
layer  of  origin,  provides  information  regarding  echogeni-
city  and  vascularity,  accurately  size  the  lesion  and  evaluate
regional  lymphadenopathies.4,5 Some  authors  suggest  that
the  diagnostic  information  on  the  subepithelial  lesions  pro-
vided  by  EUS  helps  in  deciding  whether  a  lesion  should  be
removed  or  followed  in  situ.9,10
Our  aim  was  to  analyze  the  role  of  EUS  in  the  diagnostic
approach  of  subepithelial  lesions  of  the  upper  gastrointesti-
nal  tract  (Figs.  1  and  2).2. Material and methods
Between  January  2008  and  October  2014,  324  consecutive
patients  were  referred  for  EUS  for  further  evaluation  of
i
p
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 suspected  subepithelial  lesion  discovered  at  upper  gas-
rointestinal  endoscopy.  All  cases  of  extrinsic  compression
ere  excluded  and  only  the  patients  with  conﬁrmed  SL
ere  enrolled.  For  each  patient  the  following  information
as  recorded:  demographics,  EUS  features,  presumptive
iagnosis  assessed  by  EUS  and  management  decision  after
US  (either  no  follow-up,  surveillance  with  EUS  or  addi-
ional  tissue  sampling  with  EUS-FNA  or  endoscopic  or  surgical
esection).  Based  on  other  studies,11,12 the  interval  selected
n  our  practice  was  6  months  and  1  year,  and  if  the  lesion
s  unchanged  for  2  consecutive  yearly  follow-up  examina-
ions  with  EUS  we  extended  the  length  between  surveillance
xamination.  The  following  EUS  features  were  analyzed:  site
nd  size  of  the  lesion,  wall  layer  involved,  echogenicity,
eterogeneity,  outer  margins,  presence  of  calciﬁcations  or
ystic  component  and  regional  adenopathies.
In  all  patients  careful  EUS  was  performed  using  radial
choendoscopes  at  a  scanning  frequency  of  5--10  MHz  (GF-
E160-AL5,  Olympus  ®;  Tokyo,  Japan;  ultrasound  system:
loka  ®  ProSound  Alpha  10).  High-frequency  catheter  probes
ere  not  available.  All  procedures  were  performed  on  an
utpatient  basis,  by  one  of  two  experienced  endosonogra-
hers  using  intravenous  propofol  sedation.  Written  informed
onsent  for  EUS  was  obtained  for  all  patients.  All  EUS-
NA  were  performed  in  two  other  hospitals  by  experienced
ndosonographers  and  there  was  no  on-site  cytopathologist.
he  statistical  analysis  was  performed  using  SPSS  software
ersion  20.0  (SPSS  Inc.,  Chicago,  IL,  USA).  Descriptive  statis-
ics  were  reported  as  number  and  percentage  for  categorical
ariables  and  median  (Mdn)  and  interquartile  range  (IQR)  for
uantitative  variables.  As  the  sample  did  not  follow  a  nor-
al  distribution,  the  Mann--Whitney  test  was  used  to  test
he  differences  between  size  lesions  which  were  submitted
r  not  to  additional  tissue  sampling  procedures.  The  relation
etween  each  ultrasonographic  features  and  the  decision  to
btain  biological  material  were  investigated  by  chi-square
nalysis.  EUS  predictors  of  further  therapeutic  or  diagnostic
rocedures  were  identiﬁed  using  a  binary  logistic  regression
nalysis.  Statistical  signiﬁcance  was  set  at  p  <  0.05.
.  Results
uring  the  study  period,  324  patients  were  included,  60%
ith  gastric  subepithelial  lesions,  28%  oesophageal  and
2%  from  the  duodenum.  The  mean  follow-up  after  EUS
as  41  ±  21  months.  Based  on  EUS  features  the  presump-
ive  diagnosis  was:  25%  GISTs,  21%  lipoma,  19%  leiomyoma,
7%  pancreatic  rest,  7%  submucosa  cysts,  1%  granular  cell
umors,  1%  carcinoids,  1%  mucosa  lesions  and  8%  not  deﬁned
Table  1).
After  EUS  the  suggested  approach  was  no  follow-up  in  45%
namely  lipomas,  pancreatic  rests  and  submucosal  cysts),
n  35%  follow-up  with  re-examination  with  EUS  and  in  64
atients  (20%)  EUS-FNA  or  endoscopic/surgical  resection
including  mucosa  lesions).  The  latter  was  based  on  EUS
eatures  of  risk  at  the  diagnosis  (53%),  impossibility  to
eﬁne  a  presumptive  diagnosis  (39%)  or  EUS  features  change
n  follow-up,  namely  signiﬁcant  size  increase  (8%,  only  5
atients).
The  lesion  size  had  a  median  of  10.2  (IQR  7.5--13.8  mm).
hose  which  were  submitted  to  additional  tissue  sampling
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Table  1  Presumptive  diagnosis  based  on  EUS  features.
Presumptive  diagnosis  n  (%)
GIST  81  (25%)
Lipoma 68  (21%)
Leiomyoma  62  (19%)
Pancreatic  rest  55  (17%)
Submucosa  cysts  23  (7%)
Granular  cell  tumors  3  (1%)
Carcinoids  3  (1%)
Mucosa  lesions  3  (1%)
Insufﬁcient  features  to  deﬁne  a  diagnosis 26  (8%)
Table  2  Decision  for  additional  diagnostic  or  therapeutic
strategy  based  on  the  number  of  EUS  features  considered
of risk  (size,  hypoechogenicity,  heterogeneity,  lobulation,
calciﬁcations,  cystic  component  and  regional  adenopathies).
Number  of  EUS  features
0  1  2  3  ≥4
Additional  diagnosis  or  therapeutic  strategy
No 61  167  28  4  0
Yes 2  18  19  15  10  100(%)
p < 0.001.
Table  3  Binary  logistic  regression  analysis  --  identiﬁcation
of independent  predictors  for  additional  diagnostic  or  ther-
apeutic  strategy.
Variable Odds  ratio 95%  CI  p  value
Large  size  (≥20  mm)  0.127  0.061--0.267  0.001
Hypoechogenicity  0.177  0.073--0.429  0.001
Heterogeneity  0.312  0.134--0.728  0.007
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feasible,  the  tissue  adequacy  has  been  reported  to  be  asLobulation  0.09  0.018--0.436  0.003
rocedures  were  larger  (Mdn  16.9;  IRQ  12.4--22.7)  than
hose  which  did  not  require  follow-up  or  that  were  surveyed
ith  subsequent  EUS  (Mdn  9.2;  IRQ  6.8--11.9),  U  =  13.6;
 =  15.6;  p  <  0.001.
The  EUS  features  considered  of  risk  and  used  on  the
ecision  for  additional  diagnostic  or  therapeutic  strategy
ere:  large  size  (≥20  mm)  (p  <  0.001),  hypoechogenicity
p  < 0.001),  heterogeneity  (p  <  0.001),  lobulation  (p  <  0.001),
alciﬁcations  (p  <  0.001),  cystic  component  (p  <  0.013)  and
egional  adenopathies  (p  <  0.038).  The  combination  of  mul-
iple  features  correlated  with  a  higher  probability  of  this
ecommended  strategy  (p  <  0.001),  in  100%  when  4  or  more
eatures  were  present  (Table  2).
Logistic  regression  analysis  identiﬁed  as  large  size
≥20  mm)  (p  < 0.001),  hypoechogenicity  (p  <  0.001),  hetero-
eneity  (p  <  0.007),  lobulation  (p  <  0.003)  as  independent
redictors  of  a  therapeutic  strategy  (Table  3).
In  64  patients  (20%)  EUS-FNA  or  endoscopic/surgical
esection  was  suggested  after  EUS.  Of  those  33  under-
ent  EUS-FNA  and  34  were  submitted  to  endoscopic/surgical
esection.  Among  the  33  patients  who  underwent  ﬁne  needle
spiration,  in  66%  the  result  was  inconclusive.  Of  those  who
ere  inconclusive  3  were  submitted  to  surgical  resection  and
l
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he  remaining  were  followed  by  EUS.  For  the  last  ones  who
ere  followed  by  EUS  after  inconclusive  EUS-FNA  none  were
n  the  group  of  patients  who  presented  EUS  features  change
uring  follow-up.
In those  patients  with  inconclusive  EUS-FNA  the  majority
nderwent  ﬁne  needle  aspiration  in  the  setting  of  impos-
ibility  to  deﬁne  a  presumptive  diagnosis,  without  EUS
eatures  of  risk  as  deﬁned  in  the  manuscript.  In  a  minor-
ty  of  patients  the  EUS-FNA  was  performed  twice  however
he  result  was  always  inconclusive  and  after  discussion  with
he  patients  the  decision  was  to  follow  with  EUS.  In  this
ituation  patients  were  followed  with  EUS  more  frequently,
ithout  complications  or  malignancy  related  to  SL  and  none
ere  lost  to  follow-up.
The  histological  diagnosis  were:  26  GIST,  6  leiomyoma,  4
arcinoids,  4  brunner  gland  adenomas  and  4  inﬂammatory
broid  polyps.  All  lesions  submitted  to  surgical  intervention
ere  GISTs.
During  follow-up  (41  ±  21  months)  none  of  the  patients
ho  were  managed  with  radial  EUS  for  surveillance  pre-
ented  complications,  namely  malignant  transformation.
one  of  the  patients  were  lost  to  follow-up.
For  those  patients  with  no  follow-up  (with  EUS  or
ndoscopy)  an  analysis  of  visits  to  the  hospital  or  causes
f  dead  was  made  and  in  none  of  the  patients  there  were
omplications  related  to  SL.
. Discussion
hen  a  SL  is  suspected,  after  an  upper  gastrointestinal
ndoscopy,  EUS  is  the  second  step  in  the  evaluation  of  SL
nd  adds  valuable  information  to  guide  further  manage-
ent.  EUS  is  the  diagnostic  test  of  choice  to  differentiate
etween  intramural  and  extramural  lesions,  to  assess  the
ize,  margins,  layer  of  origin,  echotexture  of  the  lesion  and
resence  of  adjacent  lymph  nodes.  Based  on  EUS  a  decision
an  be  made  to  decide  between  no  further  exams,  follow-
p  with  EUS  or  additional  diagnostic  or  therapeutic  strategy
ith  resection  when  the  lesion  is  likely  to  be  malignant.
During  the  ﬁrst  approach,  hyperechoic  and  anechoic
esions  should  be  differentiated  from  hypoechoic,  isoechoic
r  mixed  echogenic  lesions.  For  hypoechoic,  isoechoic  or
ixed  SL,  a  speciﬁc  diagnosis  is  required,  because  of  their
ossible  malignant  potential.3
The  results  of  our  study  indicate  that  EUS  seems  to  be
f  great  value  in  the  initial  evaluation  of  SL,  allowing  no
urther  examinations  in  45%  patients  without  complications
uring  follow-up.
Some  authors13 suggest  that  the  critical  step  during  EUS
xamination  is  to  recognize  the  hypoechoic  intramural  SL
rising  from  the  muscle  layers,  as  they  may  represent  GISTs.
ISTs  still  present  a particular  challenge  for  EUS,  because
ll  of  these  lesions  have  malignant  potential,  according  to
he  classiﬁcation  system  proposed  by  the  NIH  Consensus
onference.14 Tissue  diagnosis  remains  the  gold  standard
o  predict  the  risk  of  malignancy  by  evaluating  number  of
itosis/higher  power  ﬁeld.  Even  though  EUS-FNA  may  beow  as  20--57%.15,16
In  our  study  the  rate  of  failure  to  obtain  an  adequate
aterial  by  EUS-FNA  was  high  (66%),  this  can  be  explained
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by  no  on-site  cytopathologist  and  for  the  type  of  lesions.  For
this  matter,  in  a  recent  study,17 the  frequency  of  failing  to
obtain  an  adequate  material  by  EUS-FNA  was  signiﬁcantly
higher  in  patients  with  a  lesion  size  below  25  mm.  In  our
cohort  the  mean  lesion  size  that  underwent  EUS-FNA  was
17  mm  and  this  may  have  contributed  to  the  low  rate  of
adequate  material  for  diagnosis.  In  addition,  due  to  the
ﬁrm  nature  of  some  lesions,  such  as  GISTs,  which  was  our
more  frequent  presumptive  diagnosis,  cytologic  yield  may
be  poor  and  overly  blood  stained  material  which  can  difﬁcult
interpretation.16
The  possibility  to  obtain  a  tissue  core  biopsy,  preserved
tissue  architecture  and  allowing  a  histologic  examination,
was  tested  with  a  Tru-Cut  biopsy  needle  dedicated  for  EUS-
guided  ﬁne  needle  biopsy  (EUS-FNB).  However  the  technique
failed  to  reach  widespread  use  due  to  technical  difﬁculty
and  without  a  clear  advantage  as  compared  to  EUS  FNA.18 A
new  needle  designed  to  obtain  both  cytology  and  histology,
the  ProCore  ®  needles  has  been  developed  and  evaluated  in
few  studies,19,20 however  the  most  recent  studies  failed  to
demonstrate  a  signiﬁcant  difference  between  the  ProCore  ®
and  standard  FNA  needles  for  sample  adequacy,  diagnostic
accuracy  or  acquisition  of  a  core  specimen.21
Furthermore  few  studies  tried  to  assess  the  performance
characteristics  (sensitivity,  speciﬁcity  and  accuracy)  of  EUS
comparing  with  histopathology,  with  an  accuracy  found  to  be
low  (around  50%).1,5,22 However,  it  is  important  to  reinforce
that  in  these  studies  the  decision  to  obtain  tissue  was  some-
times  driven  by  diagnostic  uncertainty,  with  no  presumptive
diagnosis  suggested,  and  because  of  that  the  true  diagnos-
tic  accuracy  of  EUS  cannot  be  determined  based  on  these
results.
Although  previous  publications  questioned  the  accuracy
of  EUS  to  differentiate  between  benign  and  malignant
lesions,22,23 in  our  experience  the  role  of  EUS  to  decide  the
management  of  SL  lesions  was  actually  high.  In  this  study
the  combination  of  multiple  EUS  features  correlated  with
a  higher  probability  of  deﬁnitive  diagnosis  strategy  and/or
resection  strategy  surgical  or  endoscopic,  this  aspect  is  sup-
ported  by  the  literature.  In  one  large  multicenter  study
endosonographers  were  asked  to  assess  whether  the  EUS
changed  management  plans  and  they  reported  that  EUS
resulted  in  a  major  management  change  in  67%  of  patients
with  SL.  In  another  view,  EUS  alone  has  been  shown  to  have
sensitivity  and  a  speciﬁcity  of  64%  and  80%,  respectively,
in  the  differentiation  of  malignant  and  benign  subepithelial
lesions.23 Speciﬁcally  for  GISTs  the  simultaneous  presence
of  2  out  of  3  EUS  features  (irregular  extraluminal  margins,
cystic  spaces,  and  lymph  nodes  with  a  malignant  pattern)
has  been  shown  to  have  a  positive  predictive  value  of  100%
for  malignant  or  borderline  GISTs,24 reinforcing  that  EUS
alone  may  be  helpful  in  selecting  patients  with  higher  risk
of  malignancy.  In  our  study  we  used  EUS  features  considered
of  risk,  based  on  the  literature,24--27 to  decide  for  invasive
maneuvers  for  additional  diagnosis  or  therapeutic  strategy.
We  concluded  that  the  combination  of  multiple  features  cor-
related  with  a  higher  probability  for  this  strategy  (p  <  0.001),
and  we  veriﬁed  that  this  approach  was  conducted  in  all
patients  when  4  or  more  features  were  present.
A  multicentre  study13 of  51  patients  has  shown  that  the
majority  of  upper  gastrointestinal  subepithelial  lesions  other
than  GISTs  do  not  change  in  size  or  echogenicity  after  a291
edian  follow-up  of  23  months.  In  our  study  the  follow-
p  period  was  long,  41  months,  and  may  be  long  enough
o  reassure  the  benign  nature  of  the  lesions  followed  up  by
US.
Our  study  includes  a  large  number  of  participants  and
ong-term  follow-up  data  with  ﬁxed  speciﬁed  follow-up
ntervals,  being  the  main  limitation  to  be  a  retrospective
tudy.  We  consider  that  large  randomized  controlled  tri-
ls  with  cost-effectiveness  analysis  could  help  to  deﬁnitely
stablish  the  best  approach  for  this  type  of  lesions.
In  conclusion  our  study  suggests  that  EUS  is  capable
f  safely  and  accurately  deﬁne  those  SL  that  can  be  dis-
harged.  The  need  for  a deﬁnitive  diagnosis  or  therapeutic
pproach  can  be  based  on  ultrasound  features  of  severity,
etected  in  the  majority  of  patients  at  presentation.  The
arge  majority  of  SL  managed  with  ultrasound  surveillance
id  not  change  during  follow-up  which  may  suggest  that
arger  length  between  examinations  could  be  considered  or
ven  that  surveillance  strategy  is  not  cost-effective.
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